Risk of osteoporotic fracture in a large population-based cohort of patients with rheumatoid arthritis

Arthritis Research and Therapy

Volumn 12, Issue 4, 2010, Pages

  Kim, Seo Young ^a   Schneeweiss, Sebastian ^a   Liu, Jun ^a   Daniel, Gregory W ^b   Chang, Chun Lan ^b   Garneau, Katie ^a   Solomon, Daniel H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HEALTHCORE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; DRUG USE; FEMALE; FOLLOW UP; FRAGILITY FRACTURE; HEALTH CARE UTILIZATION; HIP FRACTURE; HUMAN; HUMERUS FRACTURE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PELVIS FRACTURE; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; WRIST FRACTURE; AGE DISTRIBUTION; FACTUAL DATABASE; FRACTURE; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; SOCIAL PSYCHOLOGY;

AGE DISTRIBUTION; ARTHRITIS, RHEUMATOID; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; FRACTURES, BONE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREJUDICE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 77955097603     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3107     Document Type: Article

References (50)

1. Rasch EK, Hirsch R, Paulose-Ram R, Hochberg MC. Prevalence of rheumatoid arthritis in persons 60 years of age and older in the United States: Effect of different methods of case classification. Arthritis Rheum 2003, 48:917-926. 10.1002/art.10897, 12687533.
2. Michaud K, Wolfe F. Comorbidities in rheumatoid arthritis. Best Pract Res Clin Rheumatol 2007, 21:885-906. 10.1016/j.berh.2007.06.002, 17870034.
3. Mikuls T, Saag K. Comorbidity in rheumatoid arthritis. Rheum Dis Clin North Am 2001, 27:283-303. 10.1016/S0889-857X(05)70202-7, 11396093.
4. Hooyman J, Melton L, Nelson A, O'Fallon W, Riggs B. Fractures after rheumatoid arthritis. A population-based study. Arthritis Rheum 1984, 27:1353-1361. 10.1002/art.1780271205, 6508860.
5. Michel B, Bloch D, Wolfe F, Fries J. Fractures in rheumatoid arthritis: an evaluation of associated risk factors. J Rheumatol 1993, 20:1666-1669.
6. Michel B, Bloch D, Fries J. Predictors of fractures in early rheumatoid arthritis. J Rheumatol 1991, 18:804-808.
7. West S, Troutner J, Baker M, Place H. Sacral insufficiency fractures in rheumatoid arthritis. Spine (Phila Pa 1976) 1994, 19:2117-2121.
8. Lane N, Pressman A, Star V, Cummings S, Nevitt M. Rheumatoid arthritis and bone mineral density in elderly women. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res 1995, 10:257-263. 10.1002/jbmr.5650100212, 7754805.
9. van Staa T, Geusens P, Bijlsma J, Leufkens H, Cooper C. Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum 2006, 54:3104-3112. 10.1002/art.22117, 17009229.
10. Haugeberg G, Uhlig T, Falch J, Halse J, Kvien T. Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register. Arthritis Rheum 2000, 43:522-530. 10.1002/1529-0131(200003)43:3<522::AID-ANR7>3.0.CO;2-Y, 10728744.
11. Kröger H, Honkanen R, Saarikoski S, Alhava E. Decreased axial bone mineral density in perimenopausal women with rheumatoid arthritis--a population based study. Ann Rheum Dis 1994, 53:18-23. 10.1136/ard.53.1.18, 1005237, 8311549.
12. Kinjo M, Setoguchi S, Solomon D. Bone mineral density in older adult patients with rheumatoid arthritis: an analysis of NHANES III. J Rheumatol 2007, 34:1971-1975.
13. Jilka R. Cytokines, bone remodeling, and estrogen deficiency: a 1998 update. Bone 1998, 23:75-81. 10.1016/S8756-3282(98)00077-5, 9701464.
14. McLean R. Proinflammatory cytokines and osteoporosis. Curr Osteoporos Rep 2009, 7:134-139. 10.1007/s11914-009-0023-2, 19968917.
15. Barnabe C, Hanley D. Effect of tumor necrosis factor alpha inhibition on bone density and turnover markers in patients with rheumatoid arthritis and spondyloarthropathy. Semin Arthritis Rheum 2009, 39:116-122. 10.1016/j.semarthrit.2008.04.004, 18585759.
16. Maugeri D, Russo M, Franzé C, Motta V, Motta M, Destro G, Speciale S, Santangelo A, Panebianco P, Malaguarnera M. Correlations between C-reactive protein, interleukin-6, tumor necrosis factor-alpha and body mass index during senile osteoporosis. Arch Gerontol Geriatr 1998, 27:159-163. 10.1016/S0167-4943(98)00110-1, 18653160.
17. Ding C, Parameswaran V, Udayan R, Burgess J, Jones G. Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study. J Clin Endocrinol Metab 2008, 93:1952-1958. 10.1210/jc.2007-2325, 18285417.
18. Cauley J, Danielson M, Boudreau R, Forrest K, Zmuda J, Pahor M, Tylavsky F, Cummings S, Harris T, Newman A, . the Health ABC Study Inflammatory markers and incident fracture risk in older men and women: the Health Aging and Body Composition Study. J Bone Miner Res 2007, 22:1088-1095. 10.1359/jbmr.070409, 17419681, the Health ABC Study.
19. Oelzner P, Schwabe A, Lehmann G, Eidner T, Franke S, Wolf G, Hein G. Significance of risk factors for osteoporosis is dependent on gender and menopause in rheumatoid arthritis. Rheumatol Int 2008, 28:1143-1150. 10.1007/s00296-008-0576-x, 18446340.
20. Koh J, Khang Y, Jung C, Bae S, Kim D, Chung Y, Kim G. Higher circulating hsCRP levels are associated with lower bone mineral density in healthy pre- and postmenopausal women: evidence for a link between systemic inflammation and osteoporosis. Osteoporos Int 2005, 16:1263-1271. 10.1007/s00198-005-1840-5, 15702263.
21. Nabipour I, Larijani B, Vahdat K, Assadi M, Jafari S, Ahmadi E, Movahed A, Moradhaseli F, Sanjdideh Z, Obeidi N, Amiri Z. Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory. Menopause 2009, 16:950-955. 10.1097/gme.0b013e3181a181b8, 19387415.
22. Nampei A, Hashimoto J, Koyanagi J, Ono T, Hashimoto H, Tsumaki N, Tomita T, Sugamoto K, Nishimoto N, Ochi T, Yoshikawa H. Characteristics of fracture and related factors in patients with rheumatoid arthritis. Mod Rheumatol 2008, 18:170-176. 10.1007/s10165-008-0032-5, 18297237.
23. Sinigaglia L, Nervetti A, Mela Q, Bianchi G, Del Puente A, Di Munno O, Frediani B, Cantatore F, Pellerito R, Bartolone S, La Montagna G, Adami S. A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis. J Rheumatol 2000, 27:2582-2589.
24. Kaz Kaz H, Johnson D, Kerry S, Chinappen U, Tweed K, Patel S. Fall-related risk factors and osteoporosis in women with rheumatoid arthritis. Rheumatology (Oxford) 2004, 43:1267-1271. 10.1093/rheumatology/keh304, 15252210.
25. Korczowska I, Olewicz-Gawlik A, Trefler J, Hrycaj P, Krzysztof Łacki J. Does low-dose and short-term glucocorticoids treatment increase the risk of osteoporosis in rheumatoid arthritis female patients?. Clin Rheumatol 2008, 27:565-572. 10.1007/s10067-007-0747-2, 17909741.
26. Coulson K, Reed G, Gilliam B, Kremer J, Pepmueller P. Factors influencing fracture risk, T score, and management of osteoporosis in patients with rheumatoid arthritis in the Consortium of Rheumatology Researchers of North America (CORRONA) registry. J Clin Rheumatol 2009, 15:155-160. 10.1097/RHU.0b013e3181a5679d, 19363452.
27. de Jong Z, Munneke M, Lems W, Zwinderman A, Kroon H, Pauwels E, Jansen A, Ronday K, Dijkmans B, Breedveld F, Vliet Vlieland TPHJ. Slowing of bone loss in patients with rheumatoid arthritis by long-term high-intensity exercise: results of a randomized, controlled trial. Arthritis Rheum 2004, 50:1066-1076. 10.1002/art.20117, 15077288.
28. Cummings S, Nevitt M, Browner W, Stone K, Fox K, Ensrud K, Cauley J, Black D, Vogt T. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 1995, 332:767-773. 10.1056/NEJM199503233321202, 7862179.
29. Dargent-Molina P, Favier F, Grandjean H, Baudoin C, Schott A, Hausherr E, Meunier P, Bréart G. Fall-related factors and risk of hip fracture: the EPIDOS prospective study. Lancet 1996, 348:145-149. 10.1016/S0140-6736(96)01440-7, 8684153.
30. Durward G, Non Pugh C, Ogunremi L, Wills R, Cottee M, Patel S. Detection of risk of falling and hip fracture in women referred for bone densitometry. Lancet 1999, 354:220-221. 10.1016/S0140-6736(99)01871-1, 10421309.
31. Leveille S, Jones R, Kiely D, Hausdorff J, Shmerling R, Guralnik J, Kiel D, Lipsitz L, Bean J. Chronic musculoskeletal pain and the occurrence of falls in an older population. JAMA 2009, 302:2214-2221. 10.1001/jama.2009.1738, 19934422.
32. Ray W, Griffin M, Fought R, Adams M. Identification of fractures from computerized Medicare files. J Clin Epidemiol 1992, 45:703-714. 10.1016/0895-4356(92)90047-Q, 1619449.
33. Deyo R, Cherkin D, Ciol M. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992, 45:613-619. 10.1016/0895-4356(92)90133-8, 1607900.
34. Schneeweiss S, Seeger J, Maclure M, Wang P, Avorn J, Glynn R. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol 2001, 154:854-864. 10.1093/aje/154.9.854, 11682368.
35. Ting G, Schneeweiss S, Scranton R, Katz J, Weinblatt M, Young M, Avorn J, Solomon D. Development of a health care utilisation data-based index for rheumatoid arthritis severity: a preliminary study. Arthritis Res Ther 2008, 10:R95. 10.1186/ar2482, 2575609, 18717997.
36. Rothman K, Greenland S, Lash T. Modern Epidemiology 2008, Philadelphia: Lippincott Williams & Wilkins, 3.
37. Kanis J, McCloskey E, Johansson H, Oden A, Ström O, Borgström F. Development and use of FRAX in osteoporosis. Osteoporos Int 2010, 21:S407-413. 10.1007/s00198-010-1253-y, 20464374.
38. Kanis J, Borgstrom F, De Laet C, Johansson H, Johnell O, Jonsson B, Oden A, Zethraeus N, Pfleger B, Khaltaev N. Assessment of fracture risk. Osteoporos Int 2005, 16:581-589. 10.1007/s00198-004-1780-5, 15616758.
39. Charlson M, Pompei P, Ales K, MacKenzie C. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383. 10.1016/0021-9681(87)90171-8, 3558716.
40. de Groot V, Beckerman H, Lankhorst G, Bouter L. How to measure comorbidity. a critical review of available methods. J Clin Epidemiol 2003, 56:221-229. 10.1016/S0895-4356(02)00585-1, 12725876.
41. Needham D, Scales D, Laupacis A, Pronovost P. A systematic review of the Charlson comorbidity index using Canadian administrative databases: a perspective on risk adjustment in critical care research. J Crit Care 2005, 20:12-19. 10.1016/j.jcrc.2004.09.007, 16015512.
42. Khurana R, Wolf R, Berney S, Caldito G, Hayat S, Berney S. Risk of development of lung cancer is increased in patients with rheumatoid arthritis: a large case control study in US veterans. J Rheumatol 2008, 35:1704-1708.
43. Setoguchi S, Schneeweiss S, Avorn J, Katz J, Weinblatt M, Levin R, Solomon D. Tumor necrosis factor-alpha antagonist use and heart failure in elderly patients with rheumatoid arthritis. Am Heart J 2008, 156:336-341. 10.1016/j.ahj.2008.02.025, 18657665.
44. Solomon D, Avorn J, Katz J, Weinblatt M, Setoguchi S, Levin R, Schneeweiss S. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis. Arthritis Rheum 2006, 54:3790-3798. 10.1002/art.22255, 17136752.
45. Ziadé N, Jougla E, Coste J. Using vital statistics to estimate the population-level impact of osteoporotic fractures on mortality based on death certificates, with an application to France (2000-2004). BMC Public Health 2009, 9:344. 10.1186/1471-2458-9-344, 2758869, 19761614.
46. Schneeweiss S, Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol 2005, 58:323-337. 10.1016/j.jclinepi.2004.10.012, 15862718.
47. Engvall I, Svensson B, Tengstrand B, Brismar K, Hafström I, . BARFOT Study Group Impact of low-dose prednisolone on bone synthesis and resorption in early rheumatoid arthritis: experiences from a two-year randomized study. Arthritis Res Ther 2008, 10:R128. 10.1186/ar2542, 2656227, 18986531, BARFOT Study Group.
48. Wijbrandts C, Klaasen R, Dijkgraaf M, Gerlag D, van Eck-Smit B, Tak P. Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss. Ann Rheum Dis 2009, 68:373-376. 10.1136/ard.2008.091611, 18408246.
49. Haugeberg G, Strand A, Kvien T, Kirwan J. Reduced loss of hand bone density with prednisolone in early rheumatoid arthritis: results from a randomized placebo-controlled trial. Arch Intern Med 2005, 165:1293-1297. 10.1001/archinte.165.11.1293, 15956010.
50. Allali F, Breban M, Porcher R, Maillefert J, Dougados M, Roux C. Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor α. Ann Rheum Dis 2003, 62:347-349. 10.1136/ard.62.4.347, 1754495, 12634235.